Cargando…

Genomics, Computational Biology and Drug Discovery for Mycobacterial Infections: Fighting the Emergence of Resistance

Tuberculosis (TB) and leprosy are mycobacterial infections caused by Mycobacterium tuberculosis and Mycobacterium leprae respectively. These diseases continue to be endemic in developing countries where the cost of new medicines presents major challenges. The situation is further exacerbated by the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Munir, Asma, Vedithi, Sundeep Chaitanya, Chaplin, Amanda K., Blundell, Tom L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498718/ https://www.ncbi.nlm.nih.gov/pubmed/33101362 http://dx.doi.org/10.3389/fgene.2020.00965

Ejemplares similares

Mycobacterial genomics and structural bioinformatics: opportunities and challenges in drug discovery
por: Waman, Vaishali P., et al.
Publicado: (2019)

Decoding the similarities and differences among mycobacterial species
por: Malhotra, Sony, et al.
Publicado: (2017)

COSMIC Cancer Gene Census 3D database: understanding the impacts of mutations on cancer targets
por: Alsulami, Ali F, et al.
Publicado: (2021)

HARP: a database of structural impacts of systematic missense mutations in drug targets of Mycobacterium leprae
por: Vedithi, Sundeep Chaitanya, et al.
Publicado: (2020)

Structure-Guided Computational Approaches to Unravel Druggable Proteomic Landscape of Mycobacterium leprae
por: Vedithi, Sundeep Chaitanya, et al.
Publicado: (2021)

Exploring the structural basis of conformational heterogeneity and autoinhibition of human cGMP-specific protein kinase Iα through computational modelling and molecular dynamics simulations
por: Maryam, Arooma, et al.
Publicado: (2020)

Computational saturation mutagenesis to predict structural consequences of systematic mutations in the beta subunit of RNA polymerase in Mycobacterium leprae
por: Vedithi, Sundeep Chaitanya, et al.
Publicado: (2020)

Mycobacterial drug discovery
por: Abrahams, Katherine A., et al.
Publicado: (2020)

SARS-CoV-2 3D database: understanding the coronavirus proteome and evaluating possible drug targets
por: Alsulami, Ali F, et al.
Publicado: (2021)

The Molecular Organization of Human cGMP Specific Phosphodiesterase 6 (PDE6): Structural Implications of Somatic Mutations in Cancer and Retinitis Pigmentosa
por: Maryam, Arooma, et al.
Publicado: (2019)

Informatics and Computational Methods in Natural Product Drug Discovery: A Review and Perspectives
por: Romano, Joseph D., et al.
Publicado: (2019)

Structural Implications of Mutations Conferring Rifampin Resistance in Mycobacterium leprae
por: Vedithi, Sundeep Chaitanya, et al.
Publicado: (2018)

Publisher Correction: Structural Implications of Mutations Conferring Rifampin Resistance in Mycobacterium leprae
por: Vedithi, Sundeep Chaitanya, et al.
Publicado: (2018)

Targeting the Proteostasis Network for Mycobacterial Drug Discovery
por: Lupoli, Tania J., et al.
Publicado: (2018)

Genomes, structural biology and drug discovery: combating the impacts of mutations in genetic disease and antibiotic resistance
por: Pandurangan, Arun Prasad, et al.
Publicado: (2017)

Using cryo-EM to understand antimycobacterial resistance in the catalase-peroxidase (KatG) from Mycobacterium tuberculosis
por: Munir, Asma, et al.
Publicado: (2021)

microRNAs in mycobacterial disease: friend or foe?
por: Mehta, Manali D., et al.
Publicado: (2014)

In silico analysis of mutations near S1/S2 cleavage site in SARS‐CoV‐2 spike protein reveals increased propensity of glycosylation in Omicron strain
por: Beaudoin, Christopher A., et al.
Publicado: (2022)

Investigation of the Genome-Wide Genetic and Epigenetic Networks for Drug Discovery Based on Systems Biology Approaches in Colorectal Cancer
por: Yeh, Shan-Ju, et al.
Publicado: (2020)

Use of Microbiota to Fight Mosquito-Borne Disease
por: Huang, Wei, et al.
Publicado: (2020)

Editorial: Enhanced biological mechanism study, drug discovery and individualized medicine with single-cell multiomics data and integrative analysis
por: Zhang, Xinying, et al.
Publicado: (2023)

Experimental Evolution Reveals Redox State Modulates Mycobacterial Pathogenicity
por: Jiang, Zheng, et al.
Publicado: (2022)

A Review of Computational Tools in microRNA Discovery
por: Gomes, Clarissa P. C., et al.
Publicado: (2013)

Small regulatory RNAs in Streptococcus pneumoniae: discovery and biological functions
por: Wilton, Joana, et al.
Publicado: (2015)

SARS-CoV-2 Omicron subvariant spike N405 unlikely to rapidly deamidate
por: Beaudoin, Christopher A., et al.
Publicado: (2023)

Methods for Detecting Mycobacterial Mixed Strain Infections–A Systematic Review
por: Byrne, Alexander Stephen, et al.
Publicado: (2020)

Prediction of rifampicin resistance beyond the RRDR using structure-based machine learning approaches
por: Portelli, Stephanie, et al.
Publicado: (2020)

CREDO: a structural interactomics database for drug discovery
por: Schreyer, Adrian M., et al.
Publicado: (2013)

Protein crystallography and drug discovery: recollections of knowledge exchange between academia and industry
por: Blundell, Tom L.
Publicado: (2017)

High-Throughput Transcriptome Profiling in Drug and Biomarker Discovery
por: Yang, Xiaonan, et al.
Publicado: (2020)

Grand Challenges in Bioinformatics and Computational Biology
por: Mushegian, Arcady
Publicado: (2011)

Computer-aided synthesis of dapsone-phytochemical conjugates against dapsone-resistant Mycobacterium leprae
por: Swain, Shasank S., et al.
Publicado: (2020)

Candidate genes and sequence variants for susceptibility to mycobacterial infection identified by whole-exome sequencing
por: Varzari, Alexander, et al.
Publicado: (2022)

Embracing the Dark Side: Computational Approaches to Unveil the Functionality of Genes Lacking Biological Annotation in Drug-Induced Liver Injury
por: Souza, Terezinha, et al.
Publicado: (2018)

Recent Trends in System-Scale Integrative Approaches for Discovering Protective Antigens Against Mycobacterial Pathogens
por: Rana, Aarti, et al.
Publicado: (2018)

Drosophila melanogaster: A platform for anticancer drug discovery and personalized therapies
por: Munnik, Chamoné, et al.
Publicado: (2022)

Shifts in Mycobacterial Populations and Emerging Drug-Resistance in West and Central Africa
por: Gehre, Florian, et al.
Publicado: (2014)

Fragment-based discovery of a new class of inhibitors targeting mycobacterial tRNA modification
por: Thomas, Sherine E, et al.
Publicado: (2020)

The Emerging Role of Non-coding RNAs in Drug Resistance of Ovarian Cancer
por: Lan, Hua, et al.
Publicado: (2021)

Adverse Drug Reaction Discovery Using a Tumor-Biomarker Knowledge Graph
por: Wang, Meng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rnmmjonoh93c2tmjhqvp98bjb5